United States Needles Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Ethicon, Medtronic Plc, B.Braun, Stryker Corporation, Novo Nordisk A/s, Boston Scientific

Needles Market is expected to grow at a CAGR 12% during the forecast period 2024-2031.

According to DataM Intelligence Comprehensive Report has released its latest report on the "Needles Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/needles-market?sg

Industry Latest News 2025:

✅ 2025-07-14 (USA) - Waters Corporation to combine with/ acquire Becton, Dickinson & Co.'s Biosciences & Diagnostic Solutions business (transaction ~$17.5B; strategic carve-out impacting BD's life-science/diagnostics footprint).

✅ 2025-11-06 (USA) - Becton, Dickinson & Co. reported FY-2025 results and reiterated M&A/portfolio rationalization activity as it proceeds with the Biosciences & Diagnostic Solutions transaction.

✅ 2025-01-15 (Japan / global) - Terumo Corporation announced the global launch of the Terumo Injection Filter Needle (integrated 5 μm mesh filter for hypodermic and intravitreal injections).

✅ 2025-11-05 (Japan) - Daicel Medical Ltd. received PMDA approval for a gas-powered needle-free injector (regulatory milestone / product approval in Japan).

✅ 2025-07-24 (Korea → USA cross-border M&A) - OSR Holdings signed a term sheet to acquire South Korea's Woori IO (non-invasive / needle-free glucose-monitoring technology); deal structure and definitive agreements were pursued through 2H-2025.

✅ 2025-10-14 (Korea / completed update) - OSR Holdings provided a strategic update/announced completion steps around the Woori IO transaction (follow-on to the July term sheet).

✅ 2025-11-04 (Europe / EMEA) - Elevaris Medical Devices (CDMO) launched/expanded procedural-needle portfolio and CDMO services into EMEA (showcased at COMPAMED/MEDICA events).

Market Geographical Share:

North America holds a significant share of the global market, primarily due to well-established healthcare infrastructure, a high number of surgical procedures, and growing adoption of safety-engineered needles to reduce needlestick injuries. The United States dominates the regional market, supported by favorable regulations promoting patient safety and infection control.

Asia-Pacific is projected to record the fastest growth during the forecast period. Rapid urbanization, rising awareness of disease prevention, and government initiatives to expand immunization coverage are major contributors. China, India, and Japan are the primary revenue-generating countries, driven by increasing demand for injectable drugs and expanding healthcare access.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/needles-market?sg

Market Drivers:

✅ Rising Prevalence of Chronic Diseases: Growing incidence of diabetes, cardiovascular disorders, and cancer is driving demand for needles used in insulin administration, biopsies, and intravenous therapies.

✅ Technological Advancements: Development of safety-engineered and retractable needles to minimize needlestick injuries enhances product adoption among healthcare professionals.

✅ Growth in Home Healthcare: The rising trend of self-administration of medications such as insulin and biologics fuels demand for user-friendly needle designs.

✅ Aging Population: An expanding elderly demographic increases the prevalence of chronic illnesses, leading to greater utilization of injectable therapies.

✅ Regulatory Support and Safety Standards: Government policies emphasizing healthcare worker safety and patient protection are encouraging the shift toward advanced, single-use needle systems.

Segments Covered in the Beverage Premix Market:

By Product (Conventional needles, Bevel needles, Safety needles, Suture needles and Others)

By End-User (Hospitals, Diagnostic Centers, Clinics and Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Beverage Premix Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=needles-market?sg

Major Key Players: Becton, Dickson and company (BD), Ethicon, Medtronic Plc, B.Braun, Stryker Corporation, Novo Nordisk A/s, Boston Scientific, Smith Medical, and Nipro Medical Corporation.

✅ Ethicon (Johnson & Johnson / Ethicon) - Ethicon is a dominant player in surgical needling/suture needles (extensive surgical-needle portfolio and long heritage in wound-closure); its position is strongest in the surgical/suture needle subsegment rather than retail hypodermic pen needles.

✅ Braun - B. Braun is a major global supplier of hypodermic needles and syringes (broad catalogue across safety needles, insulin syringes and standard hypodermic needles), giving it strong market share in hospital and diabetes (insulin) channels.

✅ Stryker Corporation - Stryker's needle footprint is narrow and specialist (needles for spine/orthopaedic and certain endoscopic/biopsy procedures); overall Stryker is not a leader in commodity hypodermic/pen-needle volumes but is important in procedure-specific needles.

✅ Novo Nordisk A/S - Novo Nordisk is a leading force in the pen-needle / insulin delivery ecosystem by virtue of its dominant diabetes franchise (although strategic moves-e.g., changes to pen product lines-have impacted pen/insulin-pen supply strategies); the company's diabetes scale makes it a key participant in the pen-needle market.

✅ Boston Scientific - Boston Scientific supplies specialised procedural needles (EUS/biopsy needles and interventional needles) used in gastroenterology, endoscopy and interventional procedures; strong presence in higher-value interventional/specialist needle categories rather than mass hypodermic needles.

✅ Smiths Medical (Smith Medical / ICU Medical portfolio overlap) - Smiths Medical (and related ICU Medical products) offers hypodermic, safety needles, Huber and infusion-related needles and has substantial supply relationships for hospital syringe/needle combinations and government procurement programs.

✅ Nipro Medical Corporation - Nipro is a major manufacturer of syringes, needles and disposable injection devices (large manufacturing footprint and diversified sales in injection/infusion supplies), giving it a meaningful share especially in Asia and OEM/contract manufacturing channels.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.